Thanks for the reply. I have one more question. Due to fright cost reduction with the same volume they will have 20-25 cr added to ebitda this FY. Is there any chance of topline coming down due to crude price falling? Because in FY22 the revenue was 1.38x over fy21 w/o much volume growth.
So due to cpp extra 20 cr to ebitda + freight cost coming down giving additional 20-25 cr ebitda should take the ebitda to 90 cr. so it’s available at forward ev/ebitda of 4.68. Historical lowest ev/ebitda around 4. So will there be any negative impact of crude price coming down on the bottom line or the gross profit level? except this negative point the company seems to be at cheap valuation.
Posts in category Value Pickr
Kanpur plastipack ltd -Outpacing commodity space, evolving through innovation (25-09-2022)
Kanpur plastipack ltd -Outpacing commodity space, evolving through innovation (25-09-2022)
In AGM I asked this Question. Being conservative management MD gave me broad range of 8-15%. However, I understand that their product will be consumed in region around Kanpur itself (Lots of Gutka and rural focussed FMCG companies are there). CPP business may generate 200 cr sales. Even with 10% margin it will contribute around 20cr to ebita.
Kanpur plastipack ltd -Outpacing commodity space, evolving through innovation (25-09-2022)
In AGM I asked this Question. Being conservative management MD gave me broad range of 8-15%. However, I understand that their product will be consumed in region around Kanpur itself (Lots of Gutka and rural focussed FMCG companies are there). CPP business may generate 200 cr sales. Even with 10% margin it will contribute around 20cr to ebita.
Meghmani Organics Ltd (25-09-2022)
Per their CEO, they are confident that by 2025, they can achieve a top line of Rs 4,500 crore and the EBITDA is likely to be around Rs 765 crore and this compares to around Rs 2,500 crore run rate last year and a PAT figure of around Rs 170 crore.
Meghmani Organics Ltd (25-09-2022)
Per their CEO, they are confident that by 2025, they can achieve a top line of Rs 4,500 crore and the EBITDA is likely to be around Rs 765 crore and this compares to around Rs 2,500 crore run rate last year and a PAT figure of around Rs 170 crore.
Dr Lal PathLabs a well recognised brand in the Diagnostic Sector (25-09-2022)
(post deleted by author)
Meghmani Organics Ltd (25-09-2022)
Agree, market is ignoring this company for quite some time, maybe because of past CG issues. TiO2 foray is not a small thing and the way india is progressing to become a major supplier of agrochem, company is rightly placed. I am expecting 900 Cr EBITDA by FY25 and basis the multiple one considers is fair for the company, the expected return can be quite handsome.
Kanpur plastipack ltd -Outpacing commodity space, evolving through innovation (25-09-2022)
what will be the margin profile for this new CPP division?